{"schema_version":"1","generated_at":"2026-11-19T01:09:55.498Z","data_as_of":null,"url":"https://www.findmykol.com/kol/michael-privitera","json_url":"https://www.findmykol.com/kol/michael-privitera/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"michael-privitera","name":"Michael Privitera","credential":"MD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Cincinnati","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1629005814"},"summary":"Michael Privitera is a Neurology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":4,"shown":3,"withheld":3,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05273398","title":"Effects of Diazepam on RNS Detections","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"University of Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT05273398","trial_url":"https://www.findmykol.com/trial/NCT05273398"},{"nct":"NCT01733394","title":"Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"University of Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT01733394","trial_url":"https://www.findmykol.com/trial/NCT01733394"},{"nct":"NCT01713777","title":"Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"University of Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT01713777","trial_url":"https://www.findmykol.com/trial/NCT01713777"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":18,"shown":3,"withheld":15,"rows":[{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2025,"amount_usd":15174.56,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629005814"},{"payer":"SK Life Science, Inc.","program_year":2025,"amount_usd":5380.63,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629005814"},{"payer":"NEUROPACE, INC.","program_year":2025,"amount_usd":2500,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629005814"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1629005814","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":98.5,"classes_total":14,"classes":[{"class":"Other antiepileptics","setting":"prescribed","share_pct":30.7,"drugs":[{"name":"Levetiracetam","share_pct":25.1},{"name":"Lacosamide","share_pct":17.2},{"name":"Topiramate","share_pct":15.2},{"name":"Xcopri","share_pct":11.3},{"name":"Epidiolex","share_pct":9.4},{"name":"Topamax","share_pct":7.2},{"name":"Keppra","share_pct":4.4},{"name":"Levetiracetam Er","share_pct":4.1},{"name":"Briviact","share_pct":2.4},{"name":"Keppra Xr","share_pct":2},{"name":"Vimpat","share_pct":1.6}],"max_beneficiaries":null},{"class":"Mood Stabilizer","setting":"prescribed","share_pct":23.4,"drugs":[{"name":"Lamotrigine","share_pct":45.7},{"name":"Carbamazepine","share_pct":20},{"name":"Lamictal","share_pct":12.6},{"name":"Carbamazepine Er","share_pct":7.3},{"name":"Carbatrol","share_pct":3},{"name":"Tegretol Xr","share_pct":2.8},{"name":"Tegretol","share_pct":2.6},{"name":"Valproic Acid","share_pct":2.5},{"name":"Lamotrigine Er","share_pct":2.4},{"name":"Lamictal Xr","share_pct":1.3}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":0.6,"classes_total":2,"classes":[{"class":"Peroxisome Proliferator-activated Receptor alpha Agonist","setting":"prescribed","share_pct":0.3,"drugs":[{"name":"Gemfibrozil","share_pct":100}],"max_beneficiaries":null},{"class":"Beta blocker","setting":"prescribed","share_pct":0.3,"drugs":[{"name":"Metoprolol Tartrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":0.5,"classes_total":1,"classes":[{"class":"Carbonic Anhydrase Inhibitor","setting":"prescribed","share_pct":0.5,"drugs":[{"name":"Acetazolamide","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":1989,"last":2000},"rows_total":11,"shown":3,"withheld":8,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"N01NS072374","title":"LOSIGAMONE AS MONOTHERAPY IN THE TREATMENT OF COMPLEX","fiscal_year":2000,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/N01NS072374"},{"project":"N01NS072374","title":"LOSIGAMONE AS MONOTHERAPY IN THE TREATMENT OF COMPLEX","fiscal_year":1998,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/N01NS072374"},{"project":"N01NS072374","title":"LOSIGAMONE AS MONOTHERAPY IN THE TREATMENT OF COMPLEX","fiscal_year":1998,"organization":"UNIVERSITY OF CINCINNATI","source_url":"https://reporter.nih.gov/quickSearch/N01NS072374"}],"source":"grants"},"contact":{"address_1":"3113 BELLEVUE AVE FL 3","city":"Cincinnati","state":"OH","zip":"452193158","phone":"513-652-6500","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1629005814","source":"identity"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"David Knopman","slug":"david-knopman","institution":"Mayo Clinic Rochester","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-knopman","json_url":"https://www.findmykol.com/kol/david-knopman/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"payments":15,"funding":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-09-25","provider_certified":"2024-09-25","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}